I know for MSB, AFR first published a report suggests biotechnology company Mesoblast (ASX: MSB), which specialises in stem cell regenerative medicine, is looking to set up a dual-listed structure with a secondary listing on the NASDAQ Stock Exchange back to end of 2013. The actual dual list went live and ADS traded on 15 Nov 2015..
Chart - Z1P, page-5651
-
- There are more pages in this discussion • 11,050 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZIP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.040(1.43%) |
Mkt cap ! $3.590B | |||
| Open | High | Low | Value | Volume |
| $2.79 | $2.85 | $2.72 | $32.47M | 11.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39955 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 144889 | 6 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| ZIP (ASX) Chart |